BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 21746967)

  • 21. Memory CD8+ T cell responses expand when antigen presentation overcomes T cell self-regulation.
    Cockburn IA; Chakravarty S; Overstreet MG; García-Sastre A; Zavala F
    J Immunol; 2008 Jan; 180(1):64-71. PubMed ID: 18097005
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Murine responses to recombinant MVA versus ALVAC vaccines against tumor-associated antigens, gp100 and 5T4.
    Hanwell DG; McNeil B; Visan L; Rodrigues L; Dunn P; Shewen PE; Macallum GE; Turner PV; Vogel TU
    J Immunother; 2013 May; 36(4):238-47. PubMed ID: 23603858
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of the class I-restricted gp100 melanoma peptide-stimulated primary immune response in tumor-free vaccine-draining lymph nodes and peripheral blood.
    Walker EB; Miller W; Haley D; Floyd K; Curti B; Urba WJ
    Clin Cancer Res; 2009 Apr; 15(7):2541-51. PubMed ID: 19318471
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD4
    Xiao M; Xie L; Cao G; Lei S; Wang P; Wei Z; Luo Y; Fang J; Yang X; Huang Q; Xu L; Guo J; Wen S; Wang Z; Wu Q; Tang J; Wang L; Chen X; Chen C; Zhang Y; Yao W; Ye J; He R; Huang J; Ye L
    J Immunother Cancer; 2022 May; 10(5):. PubMed ID: 35580929
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polyfunctional response by ImmTAC (IMCgp100) redirected CD8
    Boudousquie C; Bossi G; Hurst JM; Rygiel KA; Jakobsen BK; Hassan NJ
    Immunology; 2017 Nov; 152(3):425-438. PubMed ID: 28640942
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lentivector immunization induces tumor antigen-specific B and T cell responses in vivo.
    Garcia Casado J; Janda J; Wei J; Chapatte L; Colombetti S; Alves P; Ritter G; Ayyoub M; Valmori D; Chen W; Lévy F
    Eur J Immunol; 2008 Jul; 38(7):1867-76. PubMed ID: 18546142
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The impact of a boosting immunogen on the differentiation of secondary memory CD8+ T cells.
    Hovav AH; Panas MW; Osuna CE; Cayabyab MJ; Autissier P; Letvin NL
    J Virol; 2007 Dec; 81(23):12793-802. PubMed ID: 17881444
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of tumor-infiltrating CD8+ T cell memory precursor effector cells and antimelanoma memory responses are the result of vaccination and TGF-β blockade during the perioperative period of tumor resection.
    Bellavance EC; Kohlhapp FJ; Zloza A; O'Sullivan JA; McCracken J; Jagoda MC; Lacek AT; Posner MC; Guevara-Patino JA
    J Immunol; 2011 Mar; 186(6):3309-16. PubMed ID: 21289306
    [TBL] [Abstract][Full Text] [Related]  

  • 29. gp100(209-2M) peptide immunization of human lymphocyte antigen-A2+ stage I-III melanoma patients induces significant increase in antigen-specific effector and long-term memory CD8+ T cells.
    Walker EB; Haley D; Miller W; Floyd K; Wisner KP; Sanjuan N; Maecker H; Romero P; Hu HM; Alvord WG; Smith JW; Fox BA; Urba WJ
    Clin Cancer Res; 2004 Jan; 10(2):668-80. PubMed ID: 14760090
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effective induction of therapeutic antitumor immunity by dendritic cells coexpressing interleukin-18 and tumor antigen.
    Xia D; Zheng S; Zhang W; He L; Wang Q; Pan J; Zhang L; Wang J; Cao X
    J Mol Med (Berl); 2003 Sep; 81(9):585-96. PubMed ID: 12937899
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dendritic cells charged with apoptotic tumor cells induce long-lived protective CD4+ and CD8+ T cell immunity against B16 melanoma.
    Goldszmid RS; Idoyaga J; Bravo AI; Steinman R; Mordoh J; Wainstok R
    J Immunol; 2003 Dec; 171(11):5940-7. PubMed ID: 14634105
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Type I interferon signaling limits viral vector priming of CD8
    Riding RL; Richmond JM; Fukuda K; Harris JE
    Pigment Cell Melanoma Res; 2021 Jul; 34(4):683-695. PubMed ID: 33040466
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dendritic cell-directed lentivector vaccine induces antigen-specific immune responses against murine melanoma.
    Yang HG; Hu BL; Xiao L; Wang P
    Cancer Gene Ther; 2011 May; 18(5):370-80. PubMed ID: 21372855
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protective CD8 memory T cell responses to mouse melanoma are generated in the absence of CD4 T cell help.
    Côté AL; Byrne KT; Steinberg SM; Zhang P; Turk MJ
    PLoS One; 2011; 6(10):e26491. PubMed ID: 22046294
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Different patterns of expansion, contraction and memory differentiation of HIV-1 Gag-specific CD8 T cells elicited by adenovirus type 5 and modified vaccinia Ankara vaccines.
    Pillai VK; Kannanganat S; Penaloza-Macmaster P; Chennareddi L; Robinson HL; Blackwell J; Amara RR
    Vaccine; 2011 Jul; 29(33):5399-406. PubMed ID: 21651938
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction of antigen-specific immune responses against malignant brain tumors by intramuscular injection of sindbis DNA encoding gp100 and IL-18.
    Yamanaka R; Xanthopoulos KG
    DNA Cell Biol; 2005 May; 24(5):317-24. PubMed ID: 15869409
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nonreplicating recombinant vaccinia virus expressing CD40 ligand enhances APC capacity to stimulate specific CD4+ and CD8+ T cell responses.
    Feder-Mengus C; Schultz-Thater E; Oertli D; Marti WR; Heberer M; Spagnoli GC; Zajac P
    Hum Gene Ther; 2005 Mar; 16(3):348-60. PubMed ID: 15812230
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Strong antigen-specific T-cell immunity induced by a recombinant human TERT measles virus vaccine and amplified by a DNA/viral vector prime boost in IFNAR/CD46 mice.
    Pliquet E; Ruffie C; Escande M; Thalmensi J; Najburg V; Combredet C; Bestetti T; Julithe M; Liard C; Huet T; Wain-Hobson S; Tangy F; Langlade-Demoyen P
    Cancer Immunol Immunother; 2019 Apr; 68(4):533-544. PubMed ID: 30656384
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The immune response to melanoma is limited by thymic selection of self-antigens.
    Träger U; Sierro S; Djordjevic G; Bouzo B; Khandwala S; Meloni A; Mortensen M; Simon AK
    PLoS One; 2012; 7(4):e35005. PubMed ID: 22506061
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A multigene HIV type 1 subtype C modified vaccinia Ankara (MVA) vaccine efficiently boosts immune responses to a DNA vaccine in mice.
    Shephard E; Burgers WA; Van Harmelen JH; Monroe JE; Greenhalgh T; Williamson C; Williamson AL
    AIDS Res Hum Retroviruses; 2008 Feb; 24(2):207-17. PubMed ID: 18240963
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.